Search Results for: Therapeutic

March 24, 2025March 24, 2025

ORCHESTRA Delphi Consensus: diagnostic and therapeutic management of SARS-CoV-2 infection in haematological patients.

Publication date: Mar 21, 2025 COVID-19 poses a significant risk to individuals with haematological malignancies (HM), as they are particularly vulnerable to severe disease progression and hospitalisation due to their ... Read more

March 24, 2025March 24, 2025

Exosome-based therapeutics: Advancing drug delivery for neurodegenerative diseases.

Parkinson's Disease Literature

Publication date: Mar 21, 2025 Neurodegenerative disorders include Parkinson’s disease, spinal cord injury, multiple sclerosis and Alzheimer’s disease, cause gradual neuronal loss, protein misfolding, and accumulation, resulting in severe cognitive ... Read more

March 24, 2025March 24, 2025

Structural and virological identification of neutralizing antibody footprint provides insights into therapeutic antibody design against SARS-CoV-2 variants.

Coronavirus Literature

Publication date: Mar 22, 2025 Medical treatments using potent neutralizing SARS-CoV-2 antibodies have achieved remarkable improvements in clinical symptoms, changing the situation for the severity of COVID-19 patients. We previously ... Read more

March 24, 2025March 24, 2025

Therapeutic innovations for the symptomatic treatment of Parkinson’s disease: focus on technology-based therapies.

Parkinson's Disease Literature

Publication date: Mar 22, 2025 As Parkinson’s disease (PD) progresses, patients experience motor fluctuations, which may manifest as motor and/or non-motor wearing off symptoms, delayed “ON” time, and/or levodopa-related dyskinesia. ... Read more

March 24, 2025March 24, 2025

Clinical development of immuno-oncology therapeutics.

Melanoma Literature

Publication date: May 01, 2025 Immuno-oncology (IO) is one of the fastest growing therapeutic areas within oncology. IO agents work indirectly via the host’s adaptive and innate immune system to ... Read more

March 22, 2025March 22, 2025

Nano-healing: Exploring the Therapeutic Potentials of Nanomedicine for CNS Disorders.

Parkinson's Disease Literature

Publication date: Mar 20, 2025 Nanomedicine offers immense potential in the field of Central Nervous System (CNS) disorder treatment, encompassing conditions such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, epilepsy, ... Read more

March 22, 2025March 22, 2025

Oligonucleotide-Based Therapeutics for Neurodegenerative Disorders: Focus on Antisense Oligonucleotides.

Huntington's Disease Literature

Publication date: Mar 19, 2025 Antisense oligonucleotides (ASOs) specifically bind to target RNA sequences and regulate protein expression through various mechanisms. ASOs are a promising therapeutic approach for treating neurodegenerative ... Read more

March 22, 2025March 22, 2025

Unveiling the role of Na⁺/K⁺-ATPase pump: neurodegenerative mechanisms and therapeutic horizons.

Huntington's Disease Literature

Publication date: Mar 21, 2025 Sodium and potassium-activated adenosine 5′-triphosphatase (Na+/K+-ATPase) is a pivotal plasma membrane enzyme involved in neuronal activity and cellular homeostasis. The dysregulation of these enzymes has ... Read more

March 22, 2025March 22, 2025

Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies.

Coronavirus Literature

Publication date: Mar 20, 2025 The 2023 annual scientific meeting of the French Society of Toxicologic Pathology (SocicE9tcE9 FrancE7aise de Pathologie Toxicologique, SFPT), entitled “mRNA-based technologies: preclinical development and therapeutic ... Read more

March 22, 2025March 22, 2025

Proceedings of the 2023 Annual Scientific Meeting of the French Society of Toxicologic Pathology (SFPT) on Preclinical Development and Therapeutic Applications of mRNA-Based Technologies.

Coronavirus Literature